Shares of Arcturus Therapeutics (ARCT) are sliding on Tuesday after the company announced updated data for its COVID-19 vaccine candidate, ARCT-021. Arcturus also said… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3218788/-Street-Fight-Citi-sees-opportunity-in-Arcturus-as-COVID-data-prompts-downgrades)
previous post
next post